Demographic emergency

Italy is not a country for old people: 37% of suicides are among the elderly

Despite galloping ageing in our country, ageism, the burden of isolation and other social determinants push the elderly to the margins and cause dementia and disease

by Diego De Leo *

(Adobe Stock)

4' min read

4' min read

Loneliness and ageism, i.e. discrimination based on age, trigger a process that leads to depression. In fact, suicides among the elderly account for 37% of all suicides, although the elderly make up 24% of the general population. The phenomenon mainly affects men, cities and people over 80.

In Italy, loneliness rate twice as high as in the EU

.

Italy proves to be a particularly difficult country for the elderly, not only because of physical pathologies, but especially because of the burden of loneliness. A phenomenon that has serious consequences on mental and physical health. Loneliness is often a prelude to depression, which increases the risk of other pathologies and suicide. The rate of loneliness is twice as high as the average for European countries: those who have no one to whom they can ask for help are 14%, and those who have no one to whom they can tell personal things are 12%, compared with a European average of 6.1% (Eurostat data). Loneliness is not only a social problem, but also a clinical one, being associated with an increased risk of depression, sleep disorders, dementia and cardiovascular diseases. These issues were the focus of the 25th Congress of the Italian Association of Psychogeriatrics, organised in Padua from 27 to 29 March.

Loading...

Double risk of dementia

.

Social determinants, i.e. factors influencing health such as economic, housing and relational conditions, have a significant impact on the health of older people, although they have come to the attention of clinicians too late and are still too often neglected. According to the World Health Organisation, the impact of social determinants is equal if not greater than medical care. Therefore, ignoring these conditions poses a serious risk to people. Loneliness is a social epidemic that increases the risk of dementia by 50% and premortality by 30%; its impact is comparable to chronic smoking and obesity.

Italy without guidelines

.

Some countries have tools such as guidelines or recommendations to deal with this reality. In Italy there is still no defined approach, despite being the oldest country in the world after Japan. Several elements contribute to worsening the situation: among them, in addition to ageism, the depopulation of historic centres, the closure of local shops, and the proliferation of scams against the elderly. These elements trigger a process of debasement that leads to depression and often to suicide: suicides among the elderly are in fact 37% of the total, although the elderly make up 24% of the general population. The reason for this figure lies in the fact that our elderly are among the least 'considered' in the world. This phenomenon mainly affects men, cities and people over 80: in these sub-populations the frequency of suicides has reached intolerable levels. The suicide of an elderly person is also a terrible sign for a young person, who receives a message not of resilience but of surrender.

The spy in sleep disorders

.

The first symptoms of the consequences of an elderly person's social marginalisation on the psyche may emerge from sleep disturbances and the increased frequency of nightmares, which may in turn foster a depressive state. About 20 per cent of children and 6 per cent of adults have frequent nightmares. Persistent nightmares that interfere with daily life can be diagnosed as 'nightmare disorder', a mental health condition in which frequent and stressful nightmares can make it difficult to get through the day. The frequency of nightmares increases with age: the prevalence is more than three times higher among those over 70 years old (6.3 per cent) than among adults between 50 and 70 years old (1.8 per cent). An association with suicidal ideation, depression and stress was also found. There is a strong correlation between nightmares and suicide risk: individuals with frequent nightmares are more likely to attempt suicide and engage in self-harming behaviour.

The momentous challenge of Alzheimer's

.

However, these very advances, with ever-increasing results, also pose ethical and social challenges. In Italy, more than one million people are affected by dementia; about 60 per cent of them by Alzheimer's disease. In recent years, the first neuropathological changes have been analysed, occurring as early as 15 to 20 years before the onset of actual symptoms, with memory, speech and functional impairments. There is an increase in beta-amyloid protein, which is followed by alteration of the tau protein. New research on Alzheimer's biomarkers reveals early signs that may indicate the later onset of dementia. To detect these markers, a lumbar puncture is used to draw out the cephalrachid fluid, which surrounds the nervous system. Today, however, biomarker analyses can also be carried out using a simple blood test, making the test more accessible and potentially usable on individuals who are still asymptomatic. Knowing 20 years in advance whether one might develop Alzheimer's could represent an extraordinary advance, but also an ethical dilemma. This is the perspective the scientific community is working on. On the one hand, biomarkers have been discovered that can be identified even with a simple blood sample; on the other, certain monoclonal antibodies make it possible to slow down the course of cognitive decline. In this respect, however, progress brings new challenges, including organisational ones. The questions are numerous: which persons should be subjected to such tests; when, to what extent, and with what progression the disease will occur. Caution is therefore needed on the part of both healthcare professionals and the public. Apart from ethical and organisational problems, the drugs proposed and not yet on the Italian market are expensive and have side effects. These new monoclonal antibodies may slow down the progression of the disease, but it is not clear whether they are able to block it completely. They may, however, lead to a 20-30% slowdown, but it is not yet known whether only in the first year or also in subsequent years. However, it is estimated that only 10% of patients (with mild dementia) will benefit from these drugs, thus leaving a large majority out.

* President of the Italian Association of Psychogeriatrics.

Copyright reserved ©
Loading...

Brand connect

Loading...

Newsletter

Notizie e approfondimenti sugli avvenimenti politici, economici e finanziari.

Iscriviti